PARP regulates TGF-β receptor type II expression in estrogen receptor-positive breast cancer cell lines

Anticancer Research

Volumn 26, Issue 3 A, 2006, Pages 1893-1901

  Sterling, Julie A ^a,b   Wu, Liang ^a   Banerji, Sunandita S ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b NONE   (United States)

Author keywords

Breast cancer; CCAAT box; Estrogen receptor positive; PARP; TGF beta receptor type II

Indexed keywords

BINDING PROTEIN; CCAAT BINDING FACTOR; ESTROGEN RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME REGULATION; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IN VIVO STUDY; MASS SPECTROMETRY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PURIFICATION;

BREAST NEOPLASMS; CCAAT-BINDING FACTOR; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; POLY(ADP-RIBOSE) POLYMERASES; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 33745588297     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Donovan J and Slingerland J: Transforming growth factor-beta and breast cancer: cell cycle arrest by transforming growth factor-beta and its disruption in cancer. Breast Cancer Res 2: 116-124, 2001.
2. Attisano L and Wrana JL: Signal transduction by the TGF-beta superfamily. Science 296: 1646-1647, 2002.
3. Arteaga C, Tandon AK, Von Hoff DD and Osborne CK: Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res 48: 3898-3904, 1988.
4. Kim WS, Park C, Jung YS, Kim HS, Han J, Park CH, Kim K, Kim J, Shim YM and Park K: Reduced transforming growth factor-beta type II receptor (TGF-beta RII) expression in adenocarcinoma of the lung. Anticancer Res 19: 301-306, 1999.
5. Park K, Kim S-J, Bang Y-J, Park J-G, Kim NK, Roberts AB and Sporn MB: Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta. Proc Natl Acad Sci USA 91: 8772-8776, 1994.
6. Takenoshita S, Mogi A, Tani M, Osawa H, Sunaga H, Kakegawa H, Yanagita Y, Koida T, Kimura M, Fujita KI, Kato H, Kato R and Nagamachi Y: Absence of mutations in the analysis of coding sequences of the entire transforming growth factor-beta type II receptor gene in sporadic human breast cancers. Oncol Rep 2: 367-371, 1998
7. Vincent F, Nagashima M, Takenoshita S, Khan MA, Gemma A, Hagiwara K and Bennett WP: Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta. Oncogene 1: 117-122, 1997.
8. Chang J, Park K, Bang Y-J, Kim W, Kim D and Kim S-J: Expression of transforming growth factor beta type II receptor reduces tumorigenicity in human gastric cancer cells. Cancer Res 57: 2856-2859, 1997.
9. Sun L, Wu G, Willson JKV, Zborowska E, Yang J, Rajkarunanayake I, Wang J, Gentry LE, Wang X-F and Brattain MG: Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem 269: 26449-26455, 1994.
10. Ko Y, Banerji SS, Liu Y, Liang J, Soule HD, Pauley RJ, Willson JKV, Zborowska E and Brattain MG: Expression of transforming growth factor-beta receptor type II and tumorigenicity in human adenocarcinoma MCF-7 cells. J Cell Physiol 776: 424-434, 1998.
11. Liu Y, Zhong Z, Li W, Brattain MG and Banerji SS: The role of Sp1 in the differential expression of transforming growth factor-beta receptor type II in human breast adenocarcinoma MCF-7 cells. J Biol Chem 275: 12231-12236, 2000.
12. Nordeen SK, Green PP III and Fowlkes DM: A rapid, sensitive, and inexpensive assay for chloramphenicol acetyltransferase. DNA 6: 173-178, 1997.
13. Dignam JD, Lebovitz RM and Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475-1489, 1983.
14. Jackson SP: Identification and characterization of eukaryotic transcription factors. In: Gene Transcription: A Practical Approach (Hames BD and Higgins SJ, eds.). New York, Oxford University Press, pp. 201-205, 1993.
15. Hao H, Qi H and Ratnam M: Modulation of the folate receptor type beta gene by coordinate actions of retinoic acid receptors at activator Sp1/ets and repressor AP-1 sites. Blood 101: 4551-4660, 2003.
16. Mantovani R, Li XY, Pessara U, Hooft van Huisjduijnen R, Benoist C and Mathis D: Dominant negative analogs of NF-YA. J Biol Chem 269: 20340-20346, 1994.
17. Imbriano C, Bolognese F, Gurtner A, Piaggio G and Mantovani R: HSP-CBF is an NF-Y-dependent coactivator of the heat shock promoters CCAAT boxes. J Biol Chem 276: 26332-26339, 2001.
18. Tanimoto A, Kao C-Y, Chang C-C, Sasaguri Y and Padmanabhan R: Deregulation of cdc2 gene expression correlates with overexpression of a 110 kDa CCAAT box binding factor in transformed cells. Carcinogenesis 19: 1735-1741, 1998.
19. Lum LS, Sultzman LA, Kaufman RJ, Linzer DI and Wu BJ: A cloned human CCAAT-box-binding factor stimulates transcription from the human hsp70 promoter. Mol Cell Biol 10: 6709-6717, 1990.
20. Herzog CE and Zwelling LA: Evaluation of a potential regulatory role for inverted CCAAT boxes in the human topoisomerase II alpha promoter. Biochem Biophys Res Commun 252: 608-612, 1997.
21. Arteaga C, Coffey RJ Jr, Dugger TC, McCutchen CM, Moses HL and Lyons RM: Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta. Cell Growth Differ 1: 367-374, 1990.
22. Venkatasubbarao K, Ammanamanchi S, Brattain MG, Mimari D and Freeman JW: Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2. Cancer Res 61: 6239-6247, 2001.
23. Jennings R, Alsarraj M, Wright KL and Munoz-Antonia T: Regulation of the human transforming growth factor beta type II receptor gene promoter by novel Sp1 sites. Oncogene 20: 6899-6909, 2001.
24. Kelly D, Kim SJ and Rizzino A: Transcriptional activation of the type II transforming growth factor-beta receptor gene upon differentiation of embryonal carcinoma cells. J Biol Chem 275: 21115-21124, 1998.
25. Huang W, Zhao S, Ammanamanchi S, Brattain MG, Venkatasubbarao K and Freeman JW: Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp2 by recruitment of PCAF/p300 to a Sp1 NF-Y complex. J Biol Chem 280: 10047-10054, 2005.
26. Lee BI, Park SH, Kim JW, Sausville EA, Kim HT, Nakanishi O, Trepel JB and Kim SJ: MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells. Cancer Res 61: 931-934, 2001.
27. Currie RA: Biochemical characterization of the NF-Y transcription factor complex during B lymphocyte development. J Biol Chem 275: 1430-1434, 1998.
28. Jin S and Scotto KW: Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. Mol Cell Biol 18: 4377-4384, 1998.
29. Peng Y and Jahroudi N: The NFY transcription factor functions as a repressor and activator of the von Willebrand factor promoter. J Biol Chem 278: 8385-8394, 2003.
30. Gowri PM, Yu JH, Shaufl A, Sperling MA and Menon RK: Recruitment of a repressosome complex at the growth hormone receptor promoter and its potential role in diabetic nephropathy. Mol Cell Biol 23: 815-825, 2003.
31. Osada H, Tatematsu Y, Masuda A, Saito T, Sugiyama M, Yanogisawa K and Takahashi T: Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines. Cancer Res 61: 8331-8339, 2001.
32. Kraus WL and Lis JT: PARP goes transcription. Cell 113: 677-683, 2003
33. Ju BG, Solum D, Song EJ, Lee KJ, Rose DW, Glass CK and Rosenfeld MG: Activating the PARP-1 sensor component of the groucho/TLE1 corepressor complex mediates a CaMKinase IIdelta-dependent neurogenic gene activation pathway. Cell 119: 815-829, 2004.
34. Kim MY, Mauro S, Gevry N, Lis JT and Kraus WL: NAD+-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1. Cell 119: 803-814, 2004.
35. Althaus FR: Poly (ADP-ribose): a co-regulator of DNA methylation? Oncogene 24: 11-20, 2005.